Fidelity Investments’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,300
| Closed | -$1K | – | 4449 |
|
|
2019
Q1 | $1K | Hold |
1,300
| – | – | ﹤0.01% | 3566 |
|
|
2018
Q4 | $1K | Buy |
1,300
+469
| +56% | +$706 | ﹤0.01% | 3484 |
|
|
2018
Q3 | $2K | Buy |
+831
| New | +$1.99K | ﹤0.01% | 3429 |
|
|
2017
Q2 | – | Sell |
-985,438
| Closed | -$9.08M | – | 2761 |
|
|
2017
Q1 | $9.08M | Sell |
985,438
-17,700
| -2% | -$155K | ﹤0.01% | 2000 |
|
|
2016
Q4 | $7.73M | Buy |
1,003,138
+91,835
| +10% | +$844K | ﹤0.01% | 2054 |
|
|
2016
Q3 | $10.4M | Hold |
911,303
| – | – | ﹤0.01% | 1972 |
|
|
2016
Q2 | $11.2M | Hold |
911,303
| – | – | ﹤0.01% | 1916 |
|
|
2016
Q1 | $9.21M | Sell |
911,303
-165,117
| -15% | -$1.94M | ﹤0.01% | 1995 |
|
|
2015
Q4 | $24.3M | Buy |
1,076,420
+182,756
| +20% | +$3.74M | ﹤0.01% | 1596 |
|
|
2015
Q3 | $14.8M | Buy |
893,664
+36,598
| +4% | +$734K | ﹤0.01% | 1774 |
|
|
2015
Q2 | $19.3M | Buy |
857,066
+4,700
| +0.6% | +$116K | ﹤0.01% | 1745 |
|
|
2015
Q1 | $22M | Hold |
852,366
| – | – | ﹤0.01% | 1695 |
|
|
2014
Q4 | $18.5M | Hold |
852,366
| – | – | ﹤0.01% | 1768 |
|
|
2014
Q3 | $16.1M | Hold |
852,366
| – | – | ﹤0.01% | 1840 |
|
|
2014
Q2 | $19.9M | Buy |
852,366
+658,266
| +339% | +$16.3M | ﹤0.01% | 1801 |
|
|
2014
Q1 | $6.53M | Hold |
194,100
| – | – | ﹤0.01% | 2142 |
|
|
2013
Q4 | $5.73M | Hold |
194,100
| – | – | ﹤0.01% | 2131 |
|
|
2013
Q3 | $2.97M | Buy |
+194,100
| New | +$3.6M | ﹤0.01% | 2272 |
|
Fidelity Investments's OMED Position: Q2 2019 in Review
Fidelity Investments sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 1,300 shares — an estimated $1K sold.
Fidelity Investments first reported a position in OMED in Q3 2013 and held it in 18 quarters. The position peaked at $24.3M in Q4 2015. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.
- Fidelity Investments reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
- Fidelity Investments sold 1,300 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $1K.
- Fidelity Investments first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 18 quarters.
- Fidelity Investments's OncoMed Pharmaceuticals, Inc. position peaked at $24.3M in Q4 2015.
- 0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.
Based on Fidelity Investments's 13F filing for Q2 2019, filed 13 Aug 2019.